| # | Title | Journal | Year | Citations |
|---|
| 1 | A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment) | Blood | 2010 | 805 |
| 2 | International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia | 2009 | 686 |
| 3 | Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management | Leukemia | 2010 | 677 |
| 4 | Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy | Blood | 2007 | 563 |
| 5 | Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2015 | 458 |
| 6 | Diffuse Large B-cell Lymphomas With Plasmablastic Differentiation Represent a Heterogeneous Group of Disease Entities | American Journal of Surgical Pathology | 2004 | 392 |
| 7 | Renal Failure in Multiple Myeloma | Archives of Internal Medicine | 1998 | 328 |
| 8 | Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN) | Blood | 2011 | 309 |
| 9 | International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation | Blood | 2011 | 282 |
| 10 | Engineering and Design of Chimeric Antigen Receptors | Molecular Therapy - Methods and Clinical Development | 2019 | 281 |
| 11 | A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study | Blood | 2020 | 281 |
| 12 | p16INK4a Gene Inactivation by Deletions, Mutations, and Hypermethylation Is Associated With Transformed and Aggressive Variants of Non-Hodgkin's Lymphomas | Blood | 1998 | 266 |
| 13 | Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2021 | 265 |
| 14 | Emerging Cellular Therapies for Cancer | Annual Review of Immunology | 2019 | 263 |
| 15 | Diffuse Large B-Cell Lymphoma: Clinical and Biological Characterization and Outcome According to the Nodal or Extranodal Primary Origin | Journal of Clinical Oncology | 2005 | 253 |
| 16 | Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia | Blood | 2013 | 251 |
| 17 | Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants | Blood | 1999 | 218 |
| 18 | International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100) | Leukemia | 2009 | 207 |
| 19 | Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database | Multiple Sclerosis Journal | 2006 | 206 |
| 20 | Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens | Blood | 2009 | 203 |
| 21 | Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera | Blood | 2012 | 198 |
| 22 | COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus | Leukemia | 2020 | 198 |
| 23 | Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia | Blood | 2017 | 193 |
| 24 | Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe | Bone Marrow Transplantation | 2006 | 192 |
| 25 | Monocyte Subtypes Predict Clinical Course and Prognosis in Human Stroke | Journal of Cerebral Blood Flow and Metabolism | 2009 | 185 |
| 26 | Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents? | Blood | 2014 | 185 |
| 27 | Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma | Annals of Oncology | 2008 | 182 |
| 28 | A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts | Lancet Oncology, The | 2018 | 165 |
| 29 | Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact | Blood | 2019 | 164 |
| 30 | MicroRNA expression profiling in classic Hodgkin lymphoma | Blood | 2008 | 161 |
| 31 | Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT | Bone Marrow Transplantation | 2016 | 161 |
| 32 | Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis | Blood | 2010 | 153 |
| 33 | Follicular lymphoma | Nature Reviews Disease Primers | 2019 | 148 |
| 34 | Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study | Lancet Haematology,the | 2019 | 146 |
| 35 | Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease | Leukemia | 2012 | 141 |
| 36 | Allogeneic Stem-Cell Transplantation May Overcome the Adverse Prognosis of Unmutated VH Gene in Patients With Chronic Lymphocytic Leukemia | Journal of Clinical Oncology | 2005 | 137 |
| 37 | International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation | Leukemia | 2009 | 136 |
| 38 | Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project | Cytometry Part B - Clinical Cytometry | 2018 | 133 |
| 39 | Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both | Leukemia | 2016 | 130 |
| 40 | International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM) | Blood Cancer Journal | 2020 | 126 |
| 41 | High‐dose chemotherapy and immunotherapy in adult Burkitt lymphoma | Cancer | 2008 | 122 |
| 42 | The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab | British Journal of Haematology | 2010 | 122 |
| 43 | The number of donor CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from HLA-identical siblings | Blood | 2001 | 118 |
| 44 | New prognostic markers in chronic lymphocytic leukemia | Blood Reviews | 2008 | 118 |
| 45 | Chronic lymphocytic leukemia and autoimmunity: a systematic review | Haematologica | 2011 | 117 |
| 46 | Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone: A New, Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic Leukemia | Journal of Clinical Oncology | 2009 | 116 |
| 47 | Anti-thymocyte globulin as graft- versus -host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation | Haematologica | 2017 | 108 |
| 48 | Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B-cell receptor signaling | Blood | 2013 | 107 |
| 49 | Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network | Annals of Oncology | 2013 | 107 |
| 50 | Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status | Leukemia | 2001 | 105 |
